Scott A. Holmes, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), sold 1,441 shares at $5.97 ($9K) on 2017-05-01, disclosed to the SEC on 2017-05-03.
Open-market sale of $9k KERX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KERX | SELL | 2018-08-16 | $4K | — | Filing → |
| KERX | SELL | 2018-07-31 | $9K | — | Filing → |
| KERX | SELL | 2018-05-16 | $7K | — | Filing → |